Trifluoromethanesulfonamide

Trifluoromethanesulfonamide

SCHEMBL6602452

NS(=O)(=O)C(F)(F)F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0910415-B1 FLUORO-LABELLED ANTHRACYCLINE AND ANTHRACYCLINONE DERIVATIVES PHARMACIA ITALIA SPA (IT) 2004-05-12 EP claimed
JP-2000514784-A 2000-11-07 JP claimed
US-6103700-A FOR DIAGNOSING AMYLOIDOSIS PHARMACIA & UPJOHN S.P.A. (IT) 2000-08-15 US claimed
EP-0910415-A1 FLUORO LABELLED ANTHRACYCLINONE AND ANTHRACYCLINE DERIVATIVES PHARMACIA &amp; UPJOHN S.p.A. (IT) 1999-04-28 EP claimed
WO-1997049433-A1 FLUORO LABELLED ANTHRACYCLINONE AND ANTHRACYCLINE DERIVATIVES PHARMACIA & UPJOHN S.P.A. (IT) 1997-12-31 WO claimed
EP-0910415-B1 FLUORO-LABELLED ANTHRACYCLINE AND ANTHRACYCLINONE DERIVATIVES PHARMACIA ITALIA SPA (IT) 2004-05-12 EP disclosed
US-6103700-A FOR DIAGNOSING AMYLOIDOSIS PHARMACIA & UPJOHN S.P.A. (IT) 2000-08-15 US disclosed
EP-0910415-A1 FLUORO LABELLED ANTHRACYCLINONE AND ANTHRACYCLINE DERIVATIVES PHARMACIA &amp; UPJOHN S.p.A. (IT) 1999-04-28 EP disclosed
WO-1997049433-A1 FLUORO LABELLED ANTHRACYCLINONE AND ANTHRACYCLINE DERIVATIVES PHARMACIA & UPJOHN S.P.A. (IT) 1997-12-31 WO disclosed